#PharmaDeals
LightNews LightNews
dailystocks.bsky.social
Sun Pharma Eyes $OGN in India's Biggest Pharma Deal Ever
India's Sun Pharma eyes Organon & Co in massive $OGN acquisition
#PharmaDeals #MergersAndAcquisitions #IndianPharmaGiants

http://zip1.io/uJS7Oe
Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report
January 22, 2026 at 8:33 PM
pharmaphorum.bsky.social
Deal-hungry Ipsen is at it again, pledging around $1bn for rights to an antibody-drug conjugate (ADC) for cancer developed by China's Simcere. #pharmadeals #pharmanews
pharmaphorum.com/news/ipsen-l...
Ipsen licenses Simcere ADC in $1bn-plus deal
Deal-hungry Ipsen is at it again, pledging around $1bn for rights to an antibody-drug conjugate (ADC) for cancer developed by China's Simcere
pharmaphorum.com
December 22, 2025 at 2:05 PM
themobilebroker.bsky.social
🏆 Pfizer just beat Novo Nordisk in a $10B showdown for Metsera, one of the fiercest pharma battles since the race for COVID vaccines. The deal gives Pfizer a new shot at dominating the booming obesity drug market.

🔗 t.ly/zDK0p
#Pfizer #NovoNordisk #Metsera #PharmaDeals #ObesityDrugs
November 8, 2025 at 10:28 AM
news-x.bsky.social
These agreements boost access for ~40M gov-insured Americans & millions more paying cash. 🌍 Prices effective by Jan for cash, mid-2026 for Medicare. Lilly also cuts diabetes med prices 50-60%. 💡 #AccessToCare #PharmaDeals
November 6, 2025 at 7:14 PM
karlpopp.bsky.social
Largest acquisitions in the biotech industry in 2025 https://ow.ly/Z6qY50Xg5CG #Biotech #LifeSciences #PharmaDeals
October 23, 2025 at 7:45 PM
karlpopp.bsky.social
Largest acquisitions in the biotech industry in 2025 https://ow.ly/FFxf50Xg5Cx #Biotech #LifeSciences #PharmaDeals
October 22, 2025 at 7:45 AM
journosnews.com
AstraZeneca cuts U.S. drug prices in landmark deal with Trump administration.

#USPolitics #DrugPrices #HealthcarePolicy #PharmaDeals #TrumpAdministration
AstraZeneca Reaches Deal With Trump Administration to Lower U.S. Drug Prices
AstraZeneca Agrees to Price Reductions Under U.S. Drug Pricing Plan Published: October 13, 2025, 22:10 EDT AstraZeneca has reached an
journosnews.com
October 13, 2025 at 4:37 AM
industryexaminer.bsky.social
Causality > code. #AstraZeneca’s $555m #Algen deal skips the cap table to pay for validated targets. We decode the strategy.
👉 biotech.industryexaminer.com/astrazeneca-...

#PharmaDeals #Immunology #AI #Biotech #TechNews
AstraZeneca’s $555m Algen bet: why the pharma giant is buying AI-generated targets, not equity - Biotech Industry Examiner
AstraZeneca has inked a deal worth “up to” $555 million with San-Francisco startup Algen Biotechnologies to mine new immunology targets using AI-guided CRISPR
biotech.industryexaminer.com
October 7, 2025 at 7:55 AM
coupert.bsky.social
💊 Save big on pharmacy essentials! From skincare heroes to allergy relief & chronic care, mycare.de delivers expertise + convenience. Use exclusive coupons → gutschein.coupert.com/store/mycare.de 🎁 Free shipping, custom pill packs & pro advice included! #SaveWithCoupert #PharmaDeals #HealthHacks
mycare.de: Ihre günstige Online-Apotheke in Deutschland
In Ihrer Online-Apotheke günstige Medikamente finden: ✓ 20 Jahre Erfahrung ✓ versandkostenfrei ab 29 € ✓ E-Rezepte ✓ TÜV-zertifiziert ► Jetzt bestellen!
mycare.de
September 26, 2025 at 9:51 AM
businessquarter.bsky.social
Roche will acquire 89bio in a deal worth up to $3.5bn, adding Phase 3 liver drug pegozafermin to its pipeline. #Biotech #PharmaDeals
Roche to buy 89bio in $3.5bn deal
Roche has agreed to acquire 89bio for up to $3.5bn. The deal gives the Swiss drugmaker access to 89bio’s late-stage FGF21 therapy pegozafermin, positioning Roche to expand in liver disease and cardiometabolic treatments. The agreement includes cash and contingent value rights tied to future milestones.
businessquarter.co.uk
September 18, 2025 at 11:32 AM
china-biz-buzz.bsky.social
Lab to label? Not always.
BioNTech sold a cancer drug to BMS for $11B—originally bought from China’s Biotheus for $800M.
Early exit, or a system that leaves no better choice?
#ChinaBiotech #PharmaDeals #Econsky
June 19, 2025 at 12:01 AM
ysioscapital.bsky.social
#Speaker | Don’t miss Karen Wagner at #SwissHLG today at 13:35 !

🎤 "Managing a portfolio of minority stakes – the view from venture capital"

#VC #Biotech #PharmaDeals #LifeSciences
May 26, 2025 at 10:11 AM
royedtraining.bsky.social
💼💊 Master Biopharma Valuation!
Learn how to value early-stage compounds, forecast revenue & structure royalty deals like a pro.
📈 Perfect for BD & strategy pros in biotech & pharma.

🔗 zurl.co/0xtXc
#Biopharma #Valuation #RoyedTraining #PharmaDeals #Biotech
April 15, 2025 at 6:23 AM
openeysdown.bsky.social
5/7
⚡ Ob Pharmadeals mit Geheimverträgen, Medienförderung mit Wohlverhalten, Mandatsvergaben ohne Ausschreibungen oder Millionenaufträge an private Firmen wie die Serafe AG: Alles mit Segen von oben, alles bestens legitimiert, alles „gesetzeskonform“. Sauberer wird’s nicht.
April 10, 2025 at 2:09 PM
kstrategyand.bsky.social
www.linkedin.com/pulse/jp-mor...

JP Morgan Healthcare Conference: J&J, Eli Lilly, and GSK Spark M&A Revival in 2025

kstrategyand.com/pharma-news

#HealthcareMergers #PharmaDeals #GSK #MergersAndAcquisitions #BiotechNews #Neuroscience #Oncology #Healthcare2025 #Humanteconomy #Humantec #KStrategyand
JP Morgan Healthcare Conference: J&J, Eli Lilly, and GSK Spark M&A Revival in 2025
The financial hub of San Francisco buzzed with anticipation as the prestigious JP Morgan Healthcare Conference unfolded, setting the stage for a series of transformative announcements that could resha...
www.linkedin.com
January 23, 2025 at 11:09 AM